Pastorino U, Boeri M, Sestini S, Sabia F, et al. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Ann Oncol 2022 Jan 25. pii: S0923-7534(22)00017.
PMID: 35091076